Carmen Gonzalez

Pamplona, NC 00489, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Journal: Hematology (Amsterdam, Netherlands)
Published: June 11, 2026

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

Journal: Blood
Published: March 02, 2026

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.

Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing.

Journal: HemaSphere
Published: December 23, 2025

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients.

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients.

Journal: Frontiers in immunology
Published: May 15, 2025

Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Journal: Blood
Published: April 14, 2025

Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.

Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.

Journal: Blood
Published: April 14, 2025

Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.

Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.

Journal: Blood cancer discovery
Published: March 28, 2025

Genetic evidence against clonotypic B-lymphocytes as reservoir of plasma-cell cancers.

Genetic evidence against clonotypic B-lymphocytes as reservoir of plasma-cell cancers.

Journal: Blood cancer discovery
Published: March 28, 2025

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Journal: Blood
Published: March 14, 2025

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 01, 2024

Continuous map of early hematopoietic stem cell differentiation across human lifetime.

Continuous map of early hematopoietic stem cell differentiation across human lifetime.

Journal: Nature communications
Published: May 03, 2024

Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.

Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.

Journal: Blood neoplasia
Published: February 20, 2024
Showing 1-12 of 17

Last Updated: 09/26/2026